Epidiolex 100 mg/mL Oral Solution
3524
Approved small_molecule active
Quick answer
Epidiolex 100 mg/mL Oral Solution for Dravet Syndrome (DS) is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Dravet Syndrome (DS)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active